Personalized 3D‐Printed Affinisol‐Based Pharmaceutical Delivery Systems: The Case Study for Alternative Sulfonamides for Alzheimer's Disease
Marie Nevyhoštěná, Alena Komersová, Roman Svoboda, Vladimír Pejchal, Adéla Pospíšilová, Jan Muselík, Aleksandra Łapa, Paulina Koczurkiewicz‐Adamczyk · 2026
Read Personalized 3D‐Printed Affinisol‐Based Pharmaceutical Delivery Systems: The Case Study for Alternative Sulfonamides for Alzheimer's Disease by Marie Nevyhoštěná, Alena Komersová, Roman Svoboda, Vladimír Pejchal, Adéla Pospíšilová, Jan Muselík, Aleksandra Łapa, Paulina Koczurkiewicz‐Adamczyk (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13615160.txt.
Description
Marie Nevyhostena and co-authors explore personalized three dimensional printed drug delivery in a 2026 case study. The work targets candidate Alzheimer disease compounds that dissolve poorly in water, limiting how much drug the body can use. Personalized doses could better match patient needs in a disease with no definitive treatment.
Four sulfonamide derived compounds were loaded into printed oral tablets at varied levels using hot melt extrusion and fused deposition printing. Most tablets turned the drug amorphous, which can aid solubility. Printed forms showed favorable, sometimes sustained release, beating conventional matrix tablets on several profiles. Hardness, stability, and cell toxicity were also tested.
Catalog record
| CREATOR | Marie Nevyhoštěná, Alena Komersová, Roman Svoboda, Vladimír Pejchal, Adéla Pospíšilová, Jan Muselík, Aleksandra Łapa, Paulina Koczurkiewicz‐Adamczyk |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 54 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |